Clinical trial
CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial
NCT02365493 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CAMERA 2 - Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection - An Investigator-initiated, Multi-centre, Parallel Group, Open Labelled Randomised Controlled Trial
- Lead sponsor
- Menzies School of Health Research
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 26, 2015
- Completion date
- October 24, 2018
- Enrollment
- 358 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
methicillin-resistant staphylococcus aureus